切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2016, Vol. 12 ›› Issue (02) : 237 -240. doi: 10.3877/cma.j.issn.1673-5250.2016.02.020

所属专题: 文献

综述

不明原因复发性流产发病机制研究进展
马韵1   
  1. 1. 030001 太原,山西医科大学第一医院计划生育研究室
  • 收稿日期:2015-12-13 修回日期:2016-02-01 出版日期:2016-04-01

Research progress of pathogenesis of unexplained recurrent spontaneous abortion

Yun Ma1   

  1. 1. Department of Family Planning, First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
  • Received:2015-12-13 Revised:2016-02-01 Published:2016-04-01
  • About author:
    Corresponding author: Zheng Meiling, Email:
引用本文:

马韵. 不明原因复发性流产发病机制研究进展[J]. 中华妇幼临床医学杂志(电子版), 2016, 12(02): 237-240.

Yun Ma. Research progress of pathogenesis of unexplained recurrent spontaneous abortion[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2016, 12(02): 237-240.

复发性自然流产(RSA)病因复杂,是导致继发不孕的重要因素之一,在育龄期女性中RSA发生率为1%~5%。目前已知的导致RSA发病的危险因素包括夫妇双方染色体异常因素、子宫解剖结构异常、女性孕期内分泌功能异常、合并自身免疫性疾病,以及存在血栓前状态、感染及环境异常因素等。目前,仍有50% RSA患者未能发现明确的致病因素,这部分RSA被称为不明原因复发性流产(URSA)。近年研究发现,导致URSA发生的危险因素包括免疫系统功能异常因素、胎盘血供异常、叶酸代谢酶基因突变及精子异常因素等。笔者拟就临床对URSA发病机制的研究进展进行综述。

The causes of recurrent spontaneous abortion (RSA) are extremely complicated, and RSA has become the main cause of secondary infertility. The incidence of RSA in females during child-bearing period is 1%-5%. So far, possible risk factors of RSA include genetic abnormalities, anatomical deformities of uterus, endocrine dysfunctions during pregnancy, complicated with autoimmune diseases, pre-thrombosis, infection factors as well as environmental abnormality and so on. But the causes of more than 50% RSA are still unknown, and those RSA are called unexplained recurrent spontaneous abortion (URSA). Recent researches showed that risk factors for URSA were gradually realized, such as immune system dysfunction, abnormal placental blood supply, folate metabolism enzyme gene mutation and sperm factors and so on. This review will summarize the research progress of pathogenesis of URSA.

1
谢幸,苟文丽,主编.妇产科学.8版[M].北京:人民卫生出版社,2014:47-49.
2
Wu M, Liu P, Cheng L. Galectin-1 reduction and changes in T regulatory cells may play crucial roles in patients with unexplained recurrent spontaneous abortion[J]. Int J Clin Exp Pathol, 2015, 8(2): 1973-1978.
3
张建平,杨春凤.复发性自然流产诊治若干问题[J/CD].中华妇幼临床医学杂志:电子版,2015,11(3):292-296.
4
Sanguansermsri D, Pongcharoen S. Pregnancy immunology: decidual immune cells[J]. Asian Pac J Allergy Immunol, 2008, 26(2-3): 171-181.
5
林其德,邱丽华.免疫型复发性流产的发病机制及诊断和治疗[J].上海交通大学学报:医学版,2009,29(11):1275-1278.
6
Beydoun H, Saftlas AF. Association of human leucocyte antigen sharing with recurrent spontaneous abortions[J]. Tissue Antigens, 2005, 65(2): 123-135.
7
Stearns SC, Nesse RM, Govindaraju DR, et al. Evolutionary perspectives on health and medicine[J]. PNAS, 2010, 107(Suppl 1): 1691-1695.
8
刘翠莲,崔潋,王利飞,等.非经典HLA-Ⅰ类分子对母胎免疫耐受的调节[J].中国免疫学杂志,2015,31(5):711-714.
9
彭冰,张力,邢爱耘,等.人类白细胞抗原G和E在人早孕胎盘组织中的表达及其与反复自然流产的关系[J].四川大学学报:医学版,2008,39(6):976-979.
10
Afkhami F, Shekari KM, Farzadi L, et al. The HLA-G 14bp insertion/deletion polymorphism in women with recurrent spontaneous abortion[J]. Iran J Allergy Asthma Immunol, 2014, 13(5): 364-369.
11
王丽萍,孙燕.HLA-G 14 bp基因多态性与原因不明复发性流产的相关性[J].临床合理用药杂志,2013,6(11):3-5.
12
Romagnani S. Human TH1 and TH2 subsets: doubt no more[J]. Immunol Today, 1991, 12(8): 256-257.
13
徐澄,陆启滨.Th1/Th2细胞因子失衡致复发性流产的机制及治疗[J].长春中医药大学学报,2014,30(5):934-936.
14
邱丽华,林其德,洪燕,等.原因不明习惯性流产患者主动免疫治疗前后T辅助细胞1、2型细胞因子的变化[J].中华妇产科杂志,2001,36(7):408-410
15
Peck A, Mellins ED. Plasticity of T-cell phenotype and function: the T helper type 17 example[J]. Immunology, 2010, 129(2): 147-153.
16
蒋艳萍,曹来英,洛若愚.Th17细胞和Treg细胞与不明原因复发性流产的关系[J].武汉大学学报:医学版,2011,32(6):773-777.
17
Wang WJ, Hao CF, Yin GJ, et al. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients[J]. J Reprod Immunol, 2010, 84(2): 164-170.
18
Wu L, Luo LH, Zhang YX, et al. Alteration of Th17 and Treg cells in patients with unexplained recurrent spontaneous abortion before and after lymphocyte immunization therapy[J]. Reprod Biol Endocrinol, 2014, 12: 74.
19
Bates MD, Quengby S, Takakuwa, et al. Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss[J]. Hum Reprod, 2002, 17(9): 2439-2444.
20
Peck A, Mellins ED. Plasticity of T-cell phenotype and function: the T helper type 17 example[J]. Immunology, 2009, 129(2): 147-153.
21
林其德.原因不明复发性流产的基础与临床研究进展[J].中华妇产科杂志,2003,38(8):481-483.
22
Krussel JS, Behr B, Milki AA, et al. Vascular endothelial growth factor (VEGF) mRNA splice variants are differentially expressed in human blastocysts[J]. Mol Hum Reprod, 2001, 7(1): 57-63.
23
庞丽红,李敏清,杨冬梅,等.可溶性内皮因子受体-1(sFlt-1)与不明原因复发性流产的相关性研究[J].生殖与避孕,2011,31(1):58-61.
24
Micle O, Muresan M, Antal L. The influence of homocysteine and oxidative stress on pregnancy outcome[J]. J Med Life, 2012, 5(1): 68-73.
25
Zhang B, Denomme MM, White CR, et al. Both the floate cycle and betaine-homocysteine methyltransferase contribute methyl groups for DNA methylation in mouse blastocysts[J]. FASEB J, 2015, 29(3): 1069-1079.
26
欧阳鲁平,黄红倩,刘天盛,等.反复性流产夫妇的细胞遗传学因素探讨[J/CD].中华妇幼临床医学杂志:电子版,2015,11(5):609-612.
27
Zhu L. Polymorphisms in the methylene tetrahydrofolate reductase and methionine synthase reductase genes and their correlation with unexplained recurrent spontaneous abortion susceptibility[J]. Genet Mol Res, 2014, 14(3): 8500-8508.
28
韩红敬,沈浣,王艳槟,等.亚甲基四氢叶酸还原酶基因677位多态性,高同型半胱氨酸血症与复发性流产[J].生殖与避孕,2012,32(7):486-489.
29
胡晓东,梁佩燕,刁梁辉,等.亚甲基四氢叶酸还原酶基因突变与不明原因复发性流产的关系[J].中国优生与遗传杂志,2014,22(11):87-89.
30
Lin MH, Kuo-Kuang Lee R, Li SH, et al. Sperm chromatin structure assay parameters are not related to fertilization rates, embryo quality, and pregnancy rates in in vitro fertilization and intracytoplasmic sperm injection, but might be related to spontaneous abortion rates[J]. Fertil Steril, 2008, 90(2): 352-359.
31
刘成军,王蔼明,商微,等.精子DNA损伤与不明原因复发性流产的关系[J].中华男科学杂志,2011,17(7):619-621.
[1] 武壮壮, 张晓娟, 史泽洪, 史瑶, 原韶玲. 超声联合乳腺X线摄影及PR、Her-2预测高级别与中低级别乳腺导管原位癌的价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 631-635.
[2] 伍秋苑, 陈佩贤, 邓裕华, 何添成, 周丹. 肠道微生物在乳腺癌中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 362-365.
[3] 周婉丽, 钱铮, 李喆. 槐耳在乳腺癌免疫治疗中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 369-371.
[4] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[5] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[6] 钱龙, 陆晓峰, 王行舟, 杜峻峰, 沈晓菲, 管文贤. 神经系统调控胃肠道肿瘤免疫应答研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 86-89.
[7] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[8] 吴晨瑞, 廖锐, 贺强, 潘龙, 黄平, 曹洪祥, 赵益, 王永琛, 黄俊杰, 孙睿锐. MDT模式下肝动脉灌注化疗联合免疫靶向治疗肝细胞癌多处转移一例[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 713-716.
[9] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[10] 胡宝茹, 尚乃舰, 高迪. 中晚期肝细胞癌的DCE-MRI及DWI表现与免疫治疗预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 399-403.
[11] 梁文龙, 曹杰, 黄庆, 林泳, 黄红丽, 杨平, 李冠炜, 胡鹤. 信迪利单抗联合瑞戈非尼治疗晚期结直肠癌的疗效与安全性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 409-413.
[12] 杨镠, 秦岚群, 耿茜, 李栋庆, 戚春建, 蒋华. 可溶性免疫检查点对胃癌患者免疫治疗疗效和预后的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 305-311.
[13] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[14] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
[15] 王丁然, 迟洪滨. 自身免疫甲状腺炎对子宫内膜异位症患者胚胎移植结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 682-688.
阅读次数
全文


摘要